Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded new study locations in Canada (Nova Scotia and Quebec) under the Locations section. The HHS Vulnerability Disclosure link was removed from the footer as part of the v3.3.3 update.SummaryDifference0.3%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedFatty Liver Disease was added as a related topic and How to Prevent Diabetes was removed as a related topic.SummaryDifference0.1%

- Check47 days agoChange DetectedPublications section now includes a note that items are automatically filled from PubMed and may not all pertain to the study, and the page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check55 days agoChange DetectedNotice about government funding lapse and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedStudy Details content remains unchanged; there are no additions or deletions to the study information. The new screenshot shows only minor layout adjustments.SummaryDifference0.4%

- Check98 days agoChange DetectedUpdated page to v3.2.0 with a new government operating status notice; removed v3.1.0.SummaryDifference4%

Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.